Connor-Ahmad, Siobhan http://orcid.org/0000-0002-0748-7865
Tjeertes, Jorrit
Chladek, Michael
Newton, Louise
Symonds, Tara
Clinch, Susanne
Vincenzi, Brenda
McDougall, Fiona
Funding for this research was provided by:
Roche Products Ltd
Article History
Received: 10 October 2022
Accepted: 14 May 2023
First Online: 22 June 2023
Declarations
:
: This study was conducted in compliance with good clinical practice, including the International Conference on Harmonization Guidelines and was consistent with the most recent version of the Declaration of Helsinki. Additionally, all applicable local laws and regulatory requirements were adhered to. Before recruiting caregivers, all study documents were submitted to and approved by an independent review board. All personal data were managed to ensure accordance with applicable national and/or local laws, and regulations on personal data protection.
: Not applicable.
: BV and JT are employees of F. Hoffmann-La Roche Ltd., and BV is a shareholder. SC and SCA are employees of and shareholders in Roche Products Ltd. FM is an employee of and shareholder in Genentech Inc. TS is an employee of Clinical Outcomes Solutions Ltd., which received funding from Roche Products Ltd. for the conduct of this research. MC was an employee of Clinical Outcomes Solutions, LLC at the time of this study, and is currently an employee of IQVIA Inc. LN was an employee of Clinical Outcomes Solutions, Ltd. at the time of the study. LM is currently an employee of AstraZeneca.